Device Trial Radar · NCT06858826
Lumity CI Study - Clinical Evaluation of Next Generation Cochlear Implant Sound Processor
Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Mar 10, 2025
Primary completion
Jul 1, 2025
Study completion Jul 1, 2025
Sponsor
- Lead sponsor
- Advanced BionicsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 5, 2025
Design
- Study type
- Interventional
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective within-subjects repeated-measures study that will enroll 18 bilateral adult users implanted with a HiResolution Bionic Ear System (HiRes 90KTM, HiRes 90K TM Advantage, HiResTM Ultra, HiResTM Ultra 3D and CII with HiFocus electrode).
Conditions
- Ear Diseases
- Hearing Loss, Bilateral
- Otorhinolaryngologic Diseases
Interventions
Control cochlear implant sound processorDevice
Device: Naida M90 sound processor programmed with Target CI v1.5 software
Next Generation Sound ProcessorDevice
Device: Next generation sound processor programmed with investigation software
Primary outcomes
What the sponsor says the trial is designed to measure.
- Speech Recognition in QuietTime frame: 1 Day
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.